Small liver lesions in oncologic patients: Characterization with CT, MRI and contrast-enhanced US

Cancer Imaging

Volumn 8, Issue SPEC. ISS. A, 2008, Pages

  Morana, Giovanni ^a   Cugini, Christian ^a   Mucelli, Rafaella Pozzi ^a  

^a Radiological Department   (Italy)

Author keywords

Cancer; Characterization; Detection; Food liver lesion

Indexed keywords

CONTRAST MEDIUM; FERUCARBOTRAN; GADOBENIC ACID; GADOLINIUM CHELATE; GADOXETIC ACID; MANGAFODIPIR; PERFLUORO COMPOUND; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; HUMAN; LIVER INJURY; LIVER METASTASIS; LIVER SURGERY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PROGNOSIS; RELIABILITY;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; LIVER; MAGNETIC RESONANCE IMAGING; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55149114904     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2008.9020     Document Type: Article

References (32)

1. Quaia E, D'Onofrio M, Palumbo A, Rossi S, Bruni S, Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast- enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-609.
2. Soye JA, Mullan CP, Porter S, Beattie H, Barltrop AH, Nelson WM. The use of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Ulster Med J 2007; 76: 22-5.
3. Catala V, Nicolau C, Vilana R, et al. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 2007; 17: 1066-73.
4. Nicolau C, Vilana R, Catalá V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR 2006; 186: 158-67.
5. Dietrich CF, Kratzer W, Strobe D, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12: 1699-705.
6. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002; 222: 95-102.
7. Quaia E, Stacul F, Gaiani S, et al. Comparison of diagnostic performance of unenhanced vs Sonovue-enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. Radiol Med 2004; 108: 71-81.
8. Morin SH, Lim AK, Cobbold JF, Taylor-Robinson SD. Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions. World J Gastroenterol 2007; 13: 5963-70.
9. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images -concordance of US scans with CT scans and MR images. Radiology 2007; 242: 162-74.
10. D'Onofrio M, Martone E, Faccioli N, Zamboni G, Malagò R, Mucelli RP. Focal liver lesions: sinusoidal phase of CEUS. Abdom Imaging 2006; 31: 529-36.
11. D'Onofrio M, Rozzanigo U, Masinielli BM, et al. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography. J Clin Ultrasound 2005; 33: 164-72.
12. Celli N, Gaiani S, Piscaglia F, et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 2007; 19: 3-14.
13. Janica RJ, Lebkowska U, Ustymowicz A, et al. Contrastenhanced ultrasonography in diagnosing liver metastasis. Med Sci Monit 2007; 13(Suppl 1): 111-15.
14. Von Herbay A, Vogt C, Willers R, Haussinger D. Real-time imaging with the sonographic contrast agent Sonovue: differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004; 23: 1557-68.
15. Piscaglia F, Corradi F, Mancini M, et al. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC Cancer 2007; 7: 171-81.
16. Bartolotta TV, Taibbi A, Midiri M, Lagalla R. Focal liver lesions: contrast-enhanced ultrasound. Abdom Imaging 2008
17. Pirovano G, Vanzulli A, Marti-Bonmati L, et al. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol 2000; 175: 1111-20.
18. Morana G, Grazioli L, Testoni M, Caccia P, Procacci C. Contrast agents for hepatic magnetic resonance imaging. Top Magn Reson Imaging 2002; 13: 117-50.
19. Morana G, Grazioli L, Schneider G, et al. Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA. Acad Radiol 2002; 9(suppl 2): S476-9.
20. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008; 43: 504-11.
21. Namasivayam S, Martin DR, Saini S. Imaging of liver metastases: MRI. Cancer Imaging 2007; 7: 2-9.
22. Del Frate C, Bazzocchi M, Mortele KJ, et al. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 2002; 225: 766-72.
23. Kim HJ, Kim KW, Byun JH, et al. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. AJR Am J Roentgenol 2006; 186: 1059-66.
24. McCabe K, Tyler K, Tanabe J. Diffusion weighted MRI abnormalities as a clue to the diagnosis of herpes simplex encephalitis. Neurology 2003; 61: 1015-6.
25. Vilanova JC, Barceló J. Diffusion-weighted whole-body MR screening. Eur J Radiol 2008
26. Naganawa S, Kawai H, Fukatsu H, et al. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 2005; 31: 175-86.
27. Colagrande S, Carbone SF, Carusi LM, Cova M, Villari N. Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med 2006; 111: 392-419.
28. Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP Mr imaging and diffusionweighted imaging (DWI) alone and in combination. Eur Radiol 2008; 18: 903-10.
29. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18: 477-85.
30. Bruegel M et al. Detection of focal liver lesions: diffusionweighted respiratory triggered and breath-hold T2-weighted TSE MR imaging techniques. ESGAR 2007, e-Poster P-141.
31. Demir OI, Obuz F, Saǧol O, Dicle O. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses. Diagn Interv Radiol 2007; 13: 81-6.
32. Quan XY, Sun XJ, Yu ZJ, Tang M. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases. Hepatobiliary Pancreat Dis Int 2005; 4: 406-9.